Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-14 · accession 0001815776-24-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-15 | 2024-05-14 | LENZ | Chevallard Daniel R. | CFO | P - Purchase | $15.68 | +3,188 | 3,188 | New | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | P | A | 3,188 | $15.68 | 3,188 | D | — | — |